Monitors breathing
The system monitors breathing signals during sleep, helping your care team assess your nighttime breathing.
Please fill out the form below and we will get back to you as soon as possible.
Not all sleep apnea comes from a blocked airway. For eligible adults with central sleep apnea, the remedē System may offer another treatment option when traditional therapies have not been effective.
The remedē System is an FDA-approved implanted neurostimulation therapy for eligible adults with moderate-to-severe central sleep apnea (CSA).
In CSA, the brain does not consistently send the signals that activate breathing muscles during sleep. This differs from obstructive sleep apnea, where a physical blockage limits airflow.
remedē stimulates the phrenic nerve, which controls the diaphragm. This helps support a more regular breathing pattern and reduce interruptions during sleep.
Houston Sleep Health evaluates patients with CSA to determine whether an implantable treatment may be appropriate and helps coordinate care throughout the treatment journey.
Discuss your treatment optionsThe device is placed beneath the skin of the upper chest during an implant procedure. Your care team programs the therapy for your individual needs.
It works internally without a CPAP mask, hose, or airflow pressure. During programmed sleeping hours, therapy begins automatically when its programmed conditions are met.
Learn about your optionsThe system monitors breathing signals during sleep, helping your care team assess your nighttime breathing.
Programmed electrical stimulation is delivered to the phrenic nerve to support breathing during sleep.
Stimulation prompts the diaphragm, your main breathing muscle, to contract and help draw air into the lungs.
Therapy aims to reduce central breathing interruptions and support a more regular breathing pattern through the night.
For appropriate patients, remedē may improve sleep and quality of life. Treatment response varies with individual health and medical history.
Understanding which type of sleep apnea you have is essential because the treatment approaches differ.
| Feature | Central sleep apnea (CSA) | Obstructive sleep apnea (OSA) |
|---|---|---|
| Underlying issue | Breathing signals from the brain are interrupted or reduced during sleep. | The upper airway narrows or becomes blocked. |
| Breathing effort | Breathing muscles are not consistently activated during central events. | Airflow is restricted despite continued breathing effort. |
| Treatment options | The remedē System may be considered for eligible adults; care depends on the cause and clinical assessment. | Options may include CPAP, oral appliances, Inspire, or Genio for appropriately selected patients. |
| Associated factors | May occur with heart failure or neurological conditions, among other causes. | Often related to airway anatomy, obesity, or relaxation of upper-airway muscles during sleep. |
The remedē System may be considered for adults with moderate-to-severe CSA, including those whose symptoms persist or who have difficulty tolerating other therapies.
Your diagnosis, health history, and treatment needs are reviewed before a recommendation is made. Suitability for an implant procedure also requires assessment.
Request an evaluationLearn about the treatment, eligibility, device adjustments, and follow-up.
Ask our teamIt is an implanted neurostimulation device for moderate-to-severe central sleep apnea in eligible adults. It stimulates the phrenic nerve to activate the diaphragm and support breathing during sleep.
No. It is intended for central sleep apnea. Obstructive sleep apnea involves airway blockage and is treated with other approaches, such as CPAP, oral appliances, Inspire, or Genio when appropriate.
Yes. A qualified physician places the device beneath the skin during an implant procedure. Your treating team explains the procedure, potential risks, recovery, and follow-up.
Yes. Your care team programs the therapy and can adjust settings to your individual treatment needs and response.
Coverage depends on your plan, diagnosis, and eligibility criteria. Contact your insurer and care team to review benefits, authorization requirements, and expected costs.
The implanted battery is designed for long-term use. Device longevity varies with the system and therapy settings. Your physician can explain expected battery life, monitoring, and future replacement needs.
Adults with moderate-to-severe central sleep apnea who still have symptoms or cannot tolerate other therapies may wish to discuss an evaluation. Your specialist can assess whether remedē or another approach is suitable.
If you have central sleep apnea, Houston Sleep Health can help you understand your treatment options and whether the remedē System may be appropriate for you.